FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605610044> ?p ?o ?g. }

• W2605610044 endingPage "42816" @default.
• W2605610044 startingPage "42808" @default.
• W2605610044 abstract "// Liang Wang 1, 2 , Bin Li 1, 2 , Mo-Yuan Quan 1, 2 , Lin Li 3 , Yuan Chen 4 , Guo-Jun Tan 1, 2 , Jing Zhang 1, 2 , Xiao-Peng Liu 5 and Li Guo 1, 2 1 Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China 2 Key Laboratory of Hebei Neurology, Shijiazhuang, Hebei 050000, China 3 Department of Neurology, Tongren Hospital of Capital Medical University, Beijing, Hebei 100088, China 4 Department of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China 5 Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China Correspondence to: Li Guo, email: guoli6@163.com Keywords: oxidative stress, p38MAPK-SGK1, EAE, multiple sclerosis Received: December 08, 2016      Accepted: March 16, 2017      Published: April 12, 2017 ABSTRACT Background: Multiple sclerosis (MS), a complex disease associated with multifocal demyelination of the central nervous system and poorly understood etiology. It has been previously indicated that many factors, including oxidative stress and p38MAPK-SGK1 pathway, contribute to the pathogenesis of MS. Methods: This study, using an experimental autoimmune encephalomyelitis (EAE) model system, was aimed at investigating the molecular mechanisms determining interaction p38MAPK-SGK1 pathway and oxidative stress in MS pathogenesis. C57BL/6 mice was immunized with MOG35-55 peptide for EAE induction, which was followed by determination of the effect of treatment with classic p38 inhibitor SB203580 and antioxidant tempol on the development and progression of EAE. Results: Our experiments showed a dynamic change of immune inflammation, oxidative stress and p38MAPK-SGK1 pathway involvement in EAE demonstrating that p38MAPK-SGK1 pathway and oxidative stress contribute to the demyelination in central nerve system caused by Th17 inflammatory responses in a synergistic way. The administration of SB203580 and Tempol both markedly suppressed the progression of EAE. Furthermore, tempol showed a strong inhibiting effect to the p38MAPK-SGK1 pathway similar to SB203580 suggesting that oxidative stress exacerbates EAE via the activation of p38MAPK-SGK1 pathway. Conclusion: Cumulatively, our results show that oxidative stress p38MAPK-SGK1 signaling pathway may be a central player in EAE and even in MS." @default.
• W2605610044 created "2017-04-28" @default.
• W2605610044 creator A5003324584 @default.
• W2605610044 creator A5016675086 @default.
• W2605610044 creator A5017947172 @default.
• W2605610044 creator A5029695887 @default.
• W2605610044 creator A5052134746 @default.
• W2605610044 creator A5061760088 @default.
• W2605610044 creator A5062519157 @default.
• W2605610044 creator A5078176416 @default.
• W2605610044 creator A5086664647 @default.
• W2605610044 date "2017-04-12" @default.
• W2605610044 modified "2023-09-23" @default.
• W2605610044 title "Mechanism of oxidative stress p38MAPK-SGK1 signaling axis in experimental autoimmune encephalomyelitis (EAE)" @default.
• W2605610044 cites W1503647569 @default.
• W2605610044 cites W1505371021 @default.
• W2605610044 cites W1902487112 @default.
• W2605610044 cites W1959664751 @default.
• W2605610044 cites W1965734808 @default.
• W2605610044 cites W1981282392 @default.
• W2605610044 cites W1986173197 @default.
• W2605610044 cites W1990607809 @default.
• W2605610044 cites W1995445783 @default.
• W2605610044 cites W1999475844 @default.
• W2605610044 cites W2002208550 @default.
• W2605610044 cites W2002296282 @default.
• W2605610044 cites W2011973188 @default.
• W2605610044 cites W2021443072 @default.
• W2605610044 cites W2022848089 @default.
• W2605610044 cites W2023725391 @default.
• W2605610044 cites W2043976435 @default.
• W2605610044 cites W2046196300 @default.
• W2605610044 cites W2046766103 @default.
• W2605610044 cites W2049997594 @default.
• W2605610044 cites W2051579143 @default.
• W2605610044 cites W2055335169 @default.
• W2605610044 cites W2064220452 @default.
• W2605610044 cites W2071963896 @default.
• W2605610044 cites W2075686871 @default.
• W2605610044 cites W2076889715 @default.
• W2605610044 cites W2079246512 @default.
• W2605610044 cites W2081838607 @default.
• W2605610044 cites W2091225257 @default.
• W2605610044 cites W2092172066 @default.
• W2605610044 cites W2093321604 @default.
• W2605610044 cites W2097739088 @default.
• W2605610044 cites W2111123535 @default.
• W2605610044 cites W2114299067 @default.
• W2605610044 cites W2126009024 @default.
• W2605610044 cites W2129976411 @default.
• W2605610044 cites W2133737057 @default.
• W2605610044 cites W2140830894 @default.
• W2605610044 cites W2144110754 @default.
• W2605610044 cites W2166518409 @default.
• W2605610044 cites W2171795919 @default.
• W2605610044 cites W2257469891 @default.
• W2605610044 doi "https://doi.org/10.18632/oncotarget.17057" @default.
• W2605610044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5522107" @default.
• W2605610044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28467798" @default.
• W2605610044 hasPublicationYear "2017" @default.
• W2605610044 type Work @default.
• W2605610044 sameAs 2605610044 @default.
• W2605610044 citedByCount "19" @default.
• W2605610044 countsByYear W26056100442017 @default.
• W2605610044 countsByYear W26056100442018 @default.
• W2605610044 countsByYear W26056100442019 @default.
• W2605610044 countsByYear W26056100442020 @default.
• W2605610044 countsByYear W26056100442021 @default.
• W2605610044 countsByYear W26056100442022 @default.
• W2605610044 countsByYear W26056100442023 @default.
• W2605610044 crossrefType "journal-article" @default.
• W2605610044 hasAuthorship W2605610044A5003324584 @default.
• W2605610044 hasAuthorship W2605610044A5016675086 @default.
• W2605610044 hasAuthorship W2605610044A5017947172 @default.
• W2605610044 hasAuthorship W2605610044A5029695887 @default.
• W2605610044 hasAuthorship W2605610044A5052134746 @default.
• W2605610044 hasAuthorship W2605610044A5061760088 @default.
• W2605610044 hasAuthorship W2605610044A5062519157 @default.
• W2605610044 hasAuthorship W2605610044A5078176416 @default.
• W2605610044 hasAuthorship W2605610044A5086664647 @default.
• W2605610044 hasBestOaLocation W26056100441 @default.
• W2605610044 hasConcept C118552586 @default.
• W2605610044 hasConcept C126322002 @default.
• W2605610044 hasConcept C16568411 @default.
• W2605610044 hasConcept C203014093 @default.
• W2605610044 hasConcept C2776151105 @default.
• W2605610044 hasConcept C2778486448 @default.
• W2605610044 hasConcept C2780640218 @default.
• W2605610044 hasConcept C2780942790 @default.
• W2605610044 hasConcept C556039675 @default.
• W2605610044 hasConcept C71924100 @default.
• W2605610044 hasConcept C98274493 @default.
• W2605610044 hasConceptScore W2605610044C118552586 @default.
• W2605610044 hasConceptScore W2605610044C126322002 @default.
• W2605610044 hasConceptScore W2605610044C16568411 @default.
• W2605610044 hasConceptScore W2605610044C203014093 @default.
• W2605610044 hasConceptScore W2605610044C2776151105 @default.
• W2605610044 hasConceptScore W2605610044C2778486448 @default.

• next